Pharma News
With the Rise of GLP-1 Agonists for Treating Obesity, Will Access Challenges Prevent Progress?
![](https://meefro.com/wp-content/uploads/2024/03/With-the-Rise-of-GLP-1-Agonists-for-Treating-Obesity-Will-780x470.png)
JAMA commentary suggests that issues such as high costs, access, and equity will stop patients from obtaining GLP-1 agonists to treat obesity.
Source link
#Rise #GLP1 #Agonists #Treating #Obesity #Access #Challenges #Prevent #Progress